Status:

COMPLETED

Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer

Lead Sponsor:

Fred Hutchinson Cancer Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Breast Cancer

Eligibility:

FEMALE

25+ years

Brief Summary

RATIONALE: Collecting and storing samples of blood and studying them in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPO...

Detailed Description

OBJECTIVES: Primary * Identify and validate serum biomarkers that can distinguish malignant from benign and normal breast conditions in women at high risk or average risk for breast cancer. Seconda...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Planning to undergo outpatient annual mammogram or biopsy AND meets 1 of the following criteria:
  • High risk for breast cancer
  • High risk with newly-diagnosed\* breast cancer
  • Average risk for breast cancer
  • Average risk with newly-diagnosed\* breast cancer
  • Benign breast disease NOTE: \* Diagnosed at time of study enrollment
  • No other breast cancer diagnosis within the past year
  • Hormone receptor status:
  • Not specified
  • PATIENT CHARACTERISTICS:
  • Age
  • 25 and over
  • Sex
  • Female
  • Menopausal status
  • Not specified
  • Performance status
  • Not specified
  • Life expectancy
  • Not specified
  • Hematopoietic
  • No hemophilia
  • No other bleeding disorders
  • Hepatic
  • Not specified
  • Renal
  • Not specified
  • Other
  • Not pregnant or nursing
  • At least 6 months postpartum
  • No planned pregnancy within the next year
  • No history of medical conditions that would increase participant risk of blood draws
  • No psychiatric, psychological, or other condition that would preclude giving informed consent
  • PRIOR CONCURRENT THERAPY:
  • Biologic therapy
  • Not specified
  • Chemotherapy
  • Not specified
  • Endocrine therapy
  • Not specified
  • Radiotherapy
  • Not specified
  • Surgery
  • No prior double mastectomy
  • Other
  • No concurrent treatment for breast cancer

Exclusion

    Key Trial Info

    Start Date :

    October 1 2001

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2007

    Estimated Enrollment :

    1452 Patients enrolled

    Trial Details

    Trial ID

    NCT00897416

    Start Date

    October 1 2001

    End Date

    June 1 2007

    Last Update

    November 9 2010

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.